Not exact matches
Two Dutch scientists working for the biotechnology company GenPharm
International, based in California, received a
patent for a transgenic mouse which is deficient in T cells and is used to
study immune disorders.
Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S.
patents and 61
international patents, and an author of over 70 scientific
studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS.
SAN MARCOS, Calif, — October 7, 2015 — Natural Alternatives
International, Inc. (NAI)(NASDAQ: NAII), a global formulator and manufacturer of customized nutritional supplements, announced its expanded commitment to CarnoSyn ®, a
studied,
patent protected beta - alanine ingredient for supporting an increase in muscle carnosine and athletic performance.